{"id":"W4410408489","doi":"10.3389/fimmu.2025.1521432","title":"Efficacy of MLN9708 (ixazomib) in experimental autoimmune myasthenia gravis and in anti-AChR producing primary thymic cell cultures from myasthenia gravis patients","year":2025,"lang":"en","type":"article","venue":"Frontiers in Immunology","topic":"Myasthenia Gravis and Thymoma","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hotchkiss Brain Institute; University of Calgary","funders":"Instituto de Salud Carlos III; Ministerio de Ciencia e Innovación; European Commission; Agencia Estatal de Investigación; Takeda Pharmaceutical Company","keywords":"Myasthenia gravis; Ixazomib; Medicine; Proteasome inhibitor; Autoantibody; In vivo; Immunology; Acetylcholine receptor; Pharmacology; Multiple myeloma; Internal medicine; Antibody; Receptor; Carfilzomib; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001738729,0.0004154833,0.0004528968,0.000247877,0.0001480033,0.0001903238,0.0002005224,0.000321148,0.001042777],"category_scores_gemma":[0.0001009337,0.0001521773,0.0002875285,0.0001399306,0.0002465526,0.0001497276,0.0001162014,0.0005969663,0.0002686644],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002060094,"about_ca_system_score_gemma":0.000194031,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000745248,"about_ca_topic_score_gemma":0.001316798,"domain_scores_codex":[0.9998788,0.0000329204,0.00001121515,0.00001668643,0.00002324143,0.0000371369],"domain_scores_gemma":[0.9999346,0.00001267639,0.00001643374,0.000008485842,0.000004617018,0.00002323245],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.002463768,0.0007222701,0.000712362,0.0001005179,0.00002768532,0.0001248052,0.00004872865,0.0001810268,0.9879563,0.00004991334,0.00009525105,0.007517308],"study_design_scores_gemma":[0.0009448413,0.04011139,0.01791274,0.00001913766,0.000126257,0.0006474371,0.00006221927,0.00096527,0.9368662,0.00004016018,0.002292437,0.00001203257],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9973215,0.001600819,0.0001897459,0.00005587422,0.00002052096,0.00002580733,0.0001095051,0.00003482791,0.0006413276],"genre_scores_gemma":[0.9976241,0.0008705705,0.0002498229,0.00002423972,0.00001549177,0.00002841669,0.0002341959,0.000005122686,0.0009480451],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001042777,"threshold_uncertainty_score":0.003488481,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.004107004769938099,"score_gpt":0.2304700057891615,"score_spread":0.2263630010192234,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}